|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV059496584 |
| 003 |
DE-627 |
| 005 |
20230625013539.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
221219s2022 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.pcd.2022.10.001
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001965.pica
|
| 035 |
|
|
|a (DE-627)ELV059496584
|
| 035 |
|
|
|a (ELSEVIER)S1751-9918(22)00167-X
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 630
|q VZ
|
| 082 |
0 |
4 |
|a 640
|q VZ
|
| 082 |
0 |
4 |
|a 590
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 600
|q VZ
|
| 084 |
|
|
|a 50.70
|2 bkl
|
| 100 |
1 |
|
|a Ouchi, Dan
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic
|
| 264 |
|
1 |
|c 2022
|
| 300 |
|
|
|a 7
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a To analyse if antidiabetic treatment was associated with better COVID-19 outcomes in type 2 diabetic patients, measured by hospital admission and mortality rates as severe outcomes.
|
| 650 |
|
7 |
|a HNI
|2 Elsevier
|
| 650 |
|
7 |
|a ICD-10
|2 Elsevier
|
| 650 |
|
7 |
|a NSAID
|2 Elsevier
|
| 650 |
|
7 |
|a LTCF
|2 Elsevier
|
| 650 |
|
7 |
|a HR
|2 Elsevier
|
| 650 |
|
7 |
|a PHC
|2 Elsevier
|
| 650 |
|
7 |
|a SIDIAP
|2 Elsevier
|
| 650 |
|
7 |
|a AQuAS
|2 Elsevier
|
| 650 |
|
7 |
|a COVID-19
|2 Elsevier
|
| 650 |
|
7 |
|a DPP4
|2 Elsevier
|
| 650 |
|
7 |
|a SD
|2 Elsevier
|
| 650 |
|
7 |
|a iSGLT2
|2 Elsevier
|
| 650 |
|
7 |
|a SARS-CoV-2
|2 Elsevier
|
| 650 |
|
7 |
|a ACEI
|2 Elsevier
|
| 650 |
|
7 |
|a BMI
|2 Elsevier
|
| 650 |
|
7 |
|a OR
|2 Elsevier
|
| 650 |
|
7 |
|a CI
|2 Elsevier
|
| 650 |
|
7 |
|a GLP1
|2 Elsevier
|
| 650 |
|
7 |
|a IQR
|2 Elsevier
|
| 650 |
|
7 |
|a ECAP
|2 Elsevier
|
| 650 |
|
7 |
|a ATC
|2 Elsevier
|
| 650 |
|
7 |
|a ACE2
|2 Elsevier
|
| 650 |
|
7 |
|a ARB
|2 Elsevier
|
| 650 |
|
7 |
|a iDPP4
|2 Elsevier
|
| 650 |
|
7 |
|a PCR
|2 Elsevier
|
| 700 |
1 |
|
|a Vilaplana-Carnerero, Carles
|4 oth
|
| 700 |
1 |
|
|a de Dios, Vanessa
|4 oth
|
| 700 |
1 |
|
|a Giner-Soriano, Maria
|4 oth
|
| 700 |
1 |
|
|a Morros, Rosa
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
| 773 |
1 |
8 |
|g volume:16
|g year:2022
|g number:6
|g pages:753-759
|g extent:7
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2022.10.001
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 16
|j 2022
|e 6
|h 753-759
|g 7
|